Elite Peps Australia is a knowledge-only publication. Our editorial goal is to make peptide science, emerging therapeutics, clinical trials, laboratory methods and Australian regulation easier to understand without turning information into a sales pitch.
Evidence hierarchy
We distinguish human clinical evidence from animal studies, in-vitro findings, mechanistic hypotheses and anecdotal claims. The strength of the wording should match the strength of the evidence.
Source standards
For scientific and regulatory claims, we prioritise primary research, clinical-trial registries, regulators, peer-reviewed journals and other authoritative first-party sources. Secondary sources may provide context but should not replace stronger evidence when it is available.
Medical and safety boundaries
We do not publish personalised medical advice, dosing protocols or instructions encouraging self-administration of unapproved or prescription-only substances. Educational content should explain uncertainty, limitations and regulatory status where relevant.
Updates and transparency
Material pages should show when they were reviewed or updated. If evidence changes, we revise the page rather than preserving an outdated conclusion for traffic. Material corrections are handled under our corrections policy.
Commercial independence
The publication does not sell peptides or research compounds. Editorial decisions are made for usefulness, accuracy and reader value. Advertising, when introduced, will be visually separated from editorial content and will not determine our conclusions.